KEW Stock Overview
Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Kewaunee Scientific Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$29.00 |
| 52 Week High | US$48.80 |
| 52 Week Low | US$15.00 |
| Beta | 0.73 |
| 11 Month Change | 2.11% |
| 3 Month Change | -28.57% |
| 1 Year Change | 81.25% |
| 33 Year Change | 168.52% |
| 5 Year Change | n/a |
| Change since IPO | 176.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| KEW | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -4.5% | -0.6% |
| 1Y | 81.3% | -3.2% | 9.6% |
Return vs Industry: KEW exceeded the German Medical Equipment industry which returned -3.8% over the past year.
Return vs Market: KEW exceeded the German Market which returned 7.8% over the past year.
Price Volatility
| KEW volatility | |
|---|---|
| KEW Average Weekly Movement | 9.2% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: KEW's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: KEW's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1906 | 1,006 | Thomas Hull | www.kewaunee.com |
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Kewaunee Scientific Corporation Fundamentals Summary
| KEW fundamental statistics | |
|---|---|
| Market cap | €104.30m |
| Earnings (TTM) | €17.52m |
| Revenue (TTM) | €191.85m |
6.0x
P/E Ratio0.5x
P/S RatioIs KEW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KEW income statement (TTM) | |
|---|---|
| Revenue | US$202.31m |
| Cost of Revenue | US$149.68m |
| Gross Profit | US$52.63m |
| Other Expenses | US$34.15m |
| Earnings | US$18.47m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.43 |
| Gross Margin | 26.01% |
| Net Profit Margin | 9.13% |
| Debt/Equity Ratio | 54.9% |
How did KEW perform over the long term?
See historical performance and comparison